Leader in Medicine

Jeffrey S. Borer


The American Health Council has welcomed Dr. Jeffrey S. Borer, M.D., as “Best in Medicine,” in recognition of his extensive experience working in the field of Cardiovascular Medicine and his distinguished role as a Professor.

Dr. Jeffrey S. Borer, M.D., Professor of Medicine, Cell Biology, Radiology, Surgery and Public Health at the State University of New York Downstate Health Sciences University and Adjunct Professor of Cardiovascular Medicine in Cardiothoracic Surgery at Weill Medical College of Cornell University. With a plethora of industry experience, Dr. Borer’s knowledge and research is highly respected in the world of medicine.

For many years he served as Chief, Division of Cardiovascular Medicine and, concurrently, as Chairman, Department of Medicine, at SUNY Downstate, positions he has relinquished to concentrate on directing the two research institutes Gilman Institute for Heart Valve Disease and Schiavone Institute of Cardiovascular Translational Research Downstate. After graduating with a BA from Harvard University and subsequently a Medical Degree from Cornell University Medical College, he then went on to train and compete his residency at the Massachusetts General Hospital where he spent 7 years in the Cardiology Branch, NHLBI, and a year at Guy’s Hospital (London) as Senior Fullbright Hays Scholar and Glorney-Raisbeck Fellow in the Medical Sciences, completing the first clinical demonstration of nitroglycerin’s utility in acute MI following his preclinical studies at NIH. Upon returning to NIH, he developed stress radionuclide cineangiography, enabling the first non-invasive assessment of cardiac function with exercise and importantly changing the practice of cardiology.

After completing his Fellowships, Dr Borer returned to the NIH as a Senior Investigator where he developed Stress Radionuclide Cineangiography, an achievement which transformed the practice of cardiology by enabling the first non-invasive assessment of cardiac function with exercise. This groundbreaking development in research unmasked previously inapparent cardiac disabilities and enabled quantification of their severities.
Returning to Cornell for 30 years, as Gladys and Roland Harriman Professor of Cardiovascular Medicine and Chief, Division of Cardiovascular Pathophysiology. At Cornell and now at Downstate, he performs clinical service, teaching and research, the latter primarily in studies of regurgitant valve diseases and in clinical trials of major drug therapies. Dr. Borer performed extensive clinical service, teaching and research, his research being primarily focused on developing prognosticators for regurgitant valve diseases and assessing the effects of heart rate modification on clinical outcomes. He also carried out trials in coronary artery disease and heart failure.

A respected voice in the field, Dr. Borer has served as an advisor to the USFDA for 43 years, as chair of the CardioRenal Drugs Advisory Committee for 3 terms and of the Circulatory Devices Advisory Panel for one term. He was also a life sciences Advisor to NASA for 24 years. Currently, Dr. Borer is Chair of the Cardiovascular Devices Subcommittee of the International Standardization Organization (ISO) which sets standards for manufacture (and approval) of devices, such as heart valve replacements, for countries outside of the US.
Dr. Borer has served as officer/board member of several national professional societies including holding the title of President of the Heart Valve Society of America from 2004-2014. In addition, he has published more than 500 full-length scientific papers and chapters, 8 books, and was editor-in-chief of the journal, Cardiology, for 10 years.

Dr. Borer and has received accolades for his outstanding contributions to cardiology, several recognitions for his work including, most recently, the Lifetime Achievement Award of the Heart Valve Society of America and Society of Heart Valve Disease of Europe (2014), a Legends of Cardiology award at the 10th Annual Complex Catheter-based Cardiovascular Therapeutics conference (2014), the Albert Nelson Marquis Lifetime Achievement Award (given by Marquis “Who’s Who”), 2017, and the Kanu Chatterjee Lifetime Achievement Award for Contributions to the Field of Cardiovascular Medicine (2018) from the International Academy of Cardiology. His research has been supported by NIH, AHA and, for many years, by several large private foundations.

Outside of his commitments as a Professor at the State University of New York (and at Cornell), Dr. Borer enjoys visiting museums, physical fitness, live theatre and attending the ballet and opera. Additionally, he has maintained his affiliations with many industry organizations, associations, committees, and societies throughout his impressive career. In the future, Dr. Borer plans to continue his work in the field of cardiology, contributing his knowledge and experience to his professional and local communities.

Professor of Medicine, Cell Biology, Radiology, Public Health and Surgery at the State University of New York’s Downstate University of the Health Sciences

Adjunct Professor of Cardiovascular Medicine in Cardiothoracic Surgery at Weill Cornell Medicine